The Influence of Retinoic Acid Receptor (RAR) Status of Bladder Tumours on the Course of the Disease
- 1 December 1985
- journal article
- Published by Wiley in British Journal of Urology
- Vol. 57 (6) , 676-679
- https://doi.org/10.1111/j.1464-410x.1985.tb07030.x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Prevention of Recurrent Superficial Bladder Tumors by Oral Etretinate: Preliminary Results of a Randomized, Double Blind Multicenter Trial in SwitzerlandJournal of Urology, 1984
- Tigason® (Etretinate) in Prevention of Recurrence of Superficial Bladder TumorsEuropean Urology, 1983
- LOW SERUM-VITAMIN-A AND SUBSEQUENT RISK OF CANCERThe Lancet, 1980
- Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cellsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1980
- Retinoids and cancerCancer Chemotherapy and Pharmacology, 1979
- 13- cis -Retinoic Acid: Inhibition of Bladder Carcinogenesis in the RatScience, 1977
- Antigenic Deletion and Prognosis of Patients with Stage a Transitional Cell Bladder CarcinomaJournal of Urology, 1975
- Retinoic Acid Binding Protein: Occurrence in Human TumorsScience, 1975
- TISSUE CHANGES FOLLOWING DEPRIVATION OF FAT-SOLUBLE A VITAMINThe Journal of Experimental Medicine, 1925